Mechanism of Aminobisphosphonate Action: Characterization of Alendronate Inhibition of the Isoprenoid Pathway
- 20 December 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 266 (2), 560-563
- https://doi.org/10.1006/bbrc.1999.1849
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Geranylgeranyltransferase I Inhibitor GGTI-298 Induces Hypophosphorylation of Retinoblastoma and Partner Switching of Cyclin-dependent Kinase InhibitorsJournal of Biological Chemistry, 1999
- Nitrogen-Containing Bisphosphonates Inhibit Isopentenyl Pyrophosphate Isomerase/Farnesyl Pyrophosphate Synthase Activity with Relative Potencies Corresponding to Their Antiresorptive Potenciesin Vitroandin VivoBiochemical and Biophysical Research Communications, 1999
- Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitroProceedings of the National Academy of Sciences, 1999
- Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including RasJournal of Bone and Mineral Research, 1998
- Protein prenylation: from discovery to prospects for cancer treatmentCurrent Opinion in Chemical Biology, 1998
- Creating Isoprenoid DiversityScience, 1997
- Isoprenoid metabolism in the vertebrate retinaThe International Journal of Biochemistry & Cell Biology, 1997
- In vivo requirement of protein prenylation for maintenance of retinal cytoarchitecture and photoreceptor structure.The Journal of cell biology, 1995
- PROTEIN ISOPRENYLATION AND METHYLATION AT CARBOXYL-TERMINAL CYSTEINE RESIDUESAnnual Review of Biochemistry, 1992
- Regulation of the mevalonate pathwayNature, 1990